Motus GI Holdings, Inc.

📍 Fort Lauderdale, United States🗓 Founded 2010👥 36 employees💰 Last funded Apr 2023
Motus GI Holdings, Inc. (NASDAQ: MOTS) is a medical technology company based in the U.S., with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu® System, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The Pure-Vu® System is a 510(k) U.S. Food and Drug Administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. The Pure-Vu® System has received CE mark approval in Europe.
3
Total investors
0
Early stage
1
Mid stage
1
Late stage
2010
Founded
Investor geography2 countries
United States
2
Hong Kong SAR
1
Investor activity2015–2023 · investors recorded per year
201512019120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Motus GI Holdings, Inc.?
Motus GI Holdings, Inc. has 3 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Motus GI Holdings, Inc. last raise funding?
The most recent investment in Motus GI Holdings, Inc. recorded on gritt.io was in April 2023.
When was Motus GI Holdings, Inc. founded?
Motus GI Holdings, Inc. was founded in 2010.
What industry is Motus GI Holdings, Inc. in?
Motus GI Holdings, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Motus GI Holdings, Inc. based?
Motus GI Holdings, Inc. is headquartered in Fort Lauderdale, United States.